InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Weis Holger. Director active across 3 companies, notably Ziopharm Oncology INC. In total, 10 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €77k. Activity tracked since 4 March 2021. The latest transaction was filed on 6 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Weis Holger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
4,363 股@ US$2.01Common StockSEC:0001193125-26-344682:0
4,568 股@ US$1.920.18% mcap50.4% 占其流量Common StockSEC:0001193125-26-318105:0
85,800 股Common StockSEC:0001493152-26-033013:0
3,880 股Common StockSEC:0001193125-26-295004:0
7,761 股Common StockSEC:0001193125-26-274305:0
3,700 股@ US$2.370.12% mcap100.0% 占其流量Common StockSEC:0001193125-26-241999:0
10,781 股Common Stock, par value $0.0001 per shareSEC:0001493152-25-003549:0
40,000 股0Common StockSEC:0000899243-22-023977:0
50,000 股@ US$1.83100.0% 占其流量Common StockSEC:0001209191-21-054828:0
标准退出：2021年11月30日 (T+90)
4,167 股0Common StockSEC:0001209191-21-030746:0
10 条申报中的 10 条
About Weis Holger
Weis Holger is a director at Ziopharm Oncology INC and Alaunos Therapeutics, Inc.
